In an ideal scenario, patients with ischaemic cardiomyopathy would receive specific treatment options beyond the general heart failure management currently in place. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the unmet needs in this population and give an evaluation of surgical and percutaneous revascularization in patients with ischaemic cardiomyopathy.
The abstract entitled ‘REVIVED – Percutaneous Revascularisation for Ischaemic Ventricular Dysfunction’ was presented at the European Society of Cardiology (ESC) Congress 2022, 26 – 29 August 2022.
Questions:
- Could you give us a brief overview of the health and economic burden of heart failure due to ischaemic cardiomyopathy, and the unmet needs in its treatment? (0:21)
- What are the benefits and risks of surgical and percutaneous revascularization in patients with ischaemic cardiomyopathy? (1:43)
Disclosures: Divaka Perera has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of ESC 2022
Access more content on Heart Failure here and Cardiovascular Disease here
